Abstract
The effectiveness of public health interventions for mitigation of the coronavirus (COVID-19) pandemic depends on individual attitudes and the level of compliance toward these measures. We surveyed a representative sample of the Canadian population about risk perceptions, attitudes, and behaviours towards the Canadian COVID-19 public health response. Our analysis demonstrates that these risk perceptions, attitudes, and behaviours varied by several demographic variables identifying a number of areas in which policies could help address issues of public adherence. Examples include targeted messaging for men and younger age groups, social supports for those who need to self-isolate but may not have the means to do so, changes in workplace policies to discourage presenteeism, and provincially co-ordinated masking and safe school reopening policies. Taken together such measures are likely to mitigate the impact of the next pandemic wave in Canada.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
G.B and A.L.G. are supported by the Canada Research Chairs program. D.F.N and A.R.T are supported by the Canadian Institutes for Health Research (CIHR). Z.P. is supported by the Natural Sciences and Engineering Research Council (NSERC). E.M. and P.J.L. are supported by Heritage Canada and the Social Sciences and Humanities Research Council (SSHRC). Funding to support data collection was provided by the Public Health Agency of Canada (PHAC), The National Collaborating Centre for Infectious Diseases (NCCID), and the University of Guelph.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the University of Guelph Research Ethics Board (protocol #20-04-011) and the University of Toronto Research Ethics Board (protocol #38251).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos